BIM-23190 hydrochloride, a somatostatin analog, a selective SSRT2 and SSRT5 agonist, exhibits K i values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 can be used in the study for cancer and acromegaly.
性状
Solid
IC50 & Target[1][2]
SSTR2 SSTR5
体外研究(In Vitro)
BIM-23190 tends to mildly stimulate PRL secretion. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
BIM-23190 (50 μg/mouse, twice a day) exhibits significant anti-tumor (C6 glioma) activity. has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: Male athymic nude (nu/nu) mice, 5-6 wk old (
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Sealed storage, away from moisturePowder -80°C 2 years;-20°C 1 year
[1]. I Shimon, et al. Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors. J Clin Invest. 1997 Nov 1;100(9):2386-92.[2]. Federica Barbieri, et al. Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice. Am J Physiol Endocrinol Metab. 2009 Nov;297(5):E1078-88.
溶解度数据
In Vitro: DMSO : 100 mg/mL (80.72 mM; Need ultrasonic)H2O : 100 mg/mL (80.72 mM; Need ultrasonic)配制储备液